Drug Trial Radar · NCT06812325
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
320
Actual
Start
Feb 3, 2025
Primary completion
Apr 22, 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Viridian Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical trial assessing the safety and tolerability of an investigational drug, VRDN-003, in participants with Thyroid Eye Disease (TED).
Conditions
- Thyroid Eye Disease (TED)
Interventions
VRDN-003Drug
VRDN-003 is an investigational, subcutaneously administered, humanized monoclonal antibody directed against the Insulin-like Growth Factor-1 receptor (IGF-1R).
PlaceboDrug
Placebo injections that appear identical to VRDN-003 injections but have no active drug.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment Emergent Adverse Event (TEAE) incidence rate through Week 24Time frame: Week 24
Locations
64 sites in 7 countries. Site status is shown where the registry gives one.
Catalina Eye Care
Tuscon, Arizona
United Medical Research Institute
Inglewood, California
Orbital Plastics
Newport Beach, California
California Eye Specialists Medical Group INC
Pasadena, California
FOMAT Medical Research
Pismo Beach, California
Pacific Neuroscience Institute
Santa Monica, California
Pacific Neuroscience Institute at Saint John's Physician Partners
Torrance, California
C A Clinical Trial Corp.
Cape Coral, Florida
Herco Medical and Research Center
Coral Gables, Florida
Alfa Medical Research
Davie, Florida
D H Doral Research Center
Doral, Florida
Eye Centers of Florida
Fort Myers, Florida
Sina Medical Center
Homestead, Florida
East Coast Institute for Research, LLC
Jacksonville, Florida
Southern Clinical Research LLC
Miami, Florida
Retreat Medical Research
Miami, Florida
Continental Clinical Research
Miami, Florida
Edward Jenner Research Group LLC
Plantation, Florida
Sarasota Retina Institute
Sarasota, Florida
Advanced Quality Medical Research
Orland Park, Illinois
Ophthalmic Consultants of Boston
East Weymouth, Massachusetts
Fraser Eye Care Center
Fraser, Michigan
Mayo Clinic Rochester
Rochester, Minnesota
University of Missouri Kansas City
Kansas City, Missouri
Rutgers New Jersey Medical School
Newark, New Jersey
Jackson Clinic
Jackson, Tennessee
DFW Clinical Trials
Carrollton, Texas
Neuro Eye Clinical Trials
Houston, Texas
Pioneer Research Solutions Inc.
Houston, Texas
San Antonio Clinical Trials
San Antonio, Texas
Eyeplastx
San Antonio, Texas
Elevate Clinical Research
Seabrook, Texas
Servicde d'Endocrinologie, Diabetologieet Nutrition Centre Hospitalier Universitaire d'Angers
Angers, France
Abeillon du Payrat
Bron, France
Hôpital La Pitiélsalpêtrière
Paris, France
Charite Universitatsmeizin Berlin KoR Campus Virchow Klinikum
Berlin, Germany
Universitatsklinikum Essen
Essen, Germany
Universitaetsmedizin Goettingen
Göttingen, Germany
Johannes Gutenberg University Medical Center Department of Medicine 1
Mainz, Germany
Uniwersytecki Szpital Kliniczny w Białymstoku, Klinika Okulistyki, Centrum Badań Klinicznych
Bialystok, Poland
Showing 40 of 64 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.